HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
0.8520
+0.0314 (3.83%)
Aug 12, 2025, 9:38 AM EDT
Accolade Revenue
HOOKIPA Pharma had revenue of $2.00M in the quarter ending March 31, 2025, a decrease of -94.52%. This brings the company's revenue in the last twelve months to $9.35M, down -82.54% year-over-year. In the year 2024, HOOKIPA Pharma had annual revenue of $43.95M with 118.32% growth.
Revenue (ttm)
9.35M
Revenue Growth
-82.54%
P/S Ratio
1.11
Revenue / Employee
110.01K
Employees
87
Market Cap
10.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.95M | 23.82M | 118.32% |
| Dec 31, 2023 | 20.13M | 5.88M | 41.27% |
| Dec 31, 2022 | 14.25M | -4.20M | -22.76% |
| Dec 31, 2021 | 18.45M | -1.14M | -5.80% |
| Dec 31, 2020 | 19.58M | 7.64M | 63.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
HOOKIPA Pharma News
- 24 days ago - HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - Seeking Alpha
- 24 days ago - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - GlobeNewsWire
- 6 months ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewsWire
- 7 months ago - Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - GlobeNewsWire
- 7 months ago - HOOKIPA Pharma Inc - FORM 8 (OPD) - GlobeNewsWire
- 7 months ago - HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - GlobeNewsWire
- 7 months ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment - GlobeNewsWire
- 7 months ago - Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc. - GlobeNewsWire